Generic Name:
Azacitidine
Storage Condition:
Store below 25°C
Packing:
100 mg / Vial
Mfg / Mkd By:
Natco Pharma Ltd
Doses:
Therapeutic Use:
Description:
Introduction XPREZA 100MG INJECTION:
XPREZA 100MG INJECTION contains Azacitidine which belongs to the group of medicines called Anticancer agents. It is used in adults in the management of all sub-types of myelodysplastic syndromes (MDS, a group of cancers associated with blood and bone marrow), and certain types of blood cancer known as chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML).
CMML is a type of blood cancer where the bone marrow releases an excess amount of monocytes (a type of blood cell) into the blood stream, whereas in AML, the bone marrow releases an excess amount of immature white blood cells. Both are characterized by recurrent infections, fever, tiredness, and increased bleeding or bruising.
XPREZA 100MG INJECTION is typically used in adults who cannot undergo stem cell transplantation. Before receiving XPREZA 100MG INJECTION, inform your doctor if you have any lung, liver, kidney, or heart problems.
XPREZA 100MG INJECTION is not recommended for use by pregnant or breastfeeding women. Both men and women of childbearing potential must use a suitable contraceptive to avoid pregnancy while undergoing therapy with this medicine. Men may seek advice on sperm preservation, if necessary, prior to therapy with this medicine.
The most common side effects of receiving XPREZA 100MG INJECTION are increased bleeding, increased infections, tiredness, nausea, vomiting, diarrhea, constipation, loss of appetite, stomach pain, weakness, pain and redness at the site of injection, sore nose and throat, cold sores, headache, dizziness, trouble sleeping, weight loss, ulcers of the mouth or tongue, and hair loss. Consult your doctor if any of these side effects trouble you.
Uses of XPREZA 100MG INJECTION:
- all sub-types of myelodysplastic syndromes (MDS; a group of cancers associated with blood and bone marrow)
- Chronic myelomonocytic leukaemia (CMML; blood cancer of monocytes)
- acute myeloid leukaemia (AML; blood cancer of the WBC)
How to consume XPREZA 100MG INJECTION:
XPREZA 100MG INJECTION will be given to you only by a doctor or a nurse beneath the skin (subcutaneously) of your thighs, arms, or abdomen.
Our Other Products
View All
Fulzos (Fulvestrant) 250 mg
Generic Name: Fulvestrant

Tipanat (Trifluridine Tipiracil) 20 mg / 8.19 mg
Generic Name: Trifluridine / Tipiracil

Torinat (Everolimus) 10 mg
Generic Name: Everolimus

Trasturel (Trastuzumab) 440 mg
Generic Name: Trastuzumab
